News Releases

BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference

SAN JOSE, Calif., March 18, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced presentations at multiple upcoming investor conferences.

(PRNewsfoto/BioPharmX Corporation)

President and CEO Dr. David S. Tierney will present the latest company overview at:

  • The 31st Annual ROTH Conference on Monday, March 18 at 8:30am Pacific Time in Laguna Niguel, CA.
  • The Oppenheimer 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at 1:00pm Eastern Time in New York, NY.

About BioPharmX® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX™ Topical Delivery System for dermatology indications. To learn more about BioPharmX, visit www.BioPharmX.com.

 

SOURCE BioPharmX Corporation

For further information: investors@biopharmx.com

For more trade show news go to www.vporoom.com